<div id="content">
				<a id="top"></a>
	        		        	<h1 id="firstHeading" class="firstHeading">Drugsandbrain:References 3</h1>
				<div id="bodyContent">
		            <h3 id="siteSub">From Coursera</h3>
		            <div id="contentSub"></div>
		            		            		            					<!-- start content -->
					<div lang="en" dir="ltr" class="mw-content-ltr"><p>References, Week 3<br />
Add references, including links to <a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Open-access_journal">Open-access journals</a> and articles for items that are mentioned in the course.</p>
<table id="toc" class="toc"><tr><td><div id="toctitle"><h2>Contents</h2></div>
<ul>
<li class="toclevel-1"><a href="#Drugs_Bind_to_Neurotransmitter_Transporters_.2822.29"><span class="tocnumber">1</span> <span class="toctext">Drugs Bind to Neurotransmitter Transporters (22)</span></a></li>
<li class="toclevel-1"><a href="#Neurotransmitter_Transporters_as_Molecules_.2823.29"><span class="tocnumber">2</span> <span class="toctext">Neurotransmitter Transporters as Molecules (23)</span></a></li>
<li class="toclevel-1"><a href="#Recreational_Drugs:"><span class="tocnumber">3</span> <span class="toctext">Recreational  Drugs:</span></a>
<ul>
<li class="toclevel-2"><a href="#Overview_.2824.29"><span class="tocnumber">3.1</span> <span class="toctext">Overview (24)</span></a></li>
<li class="toclevel-2"><a href="#Targets_.2825.29"><span class="tocnumber">3.2</span> <span class="toctext">Targets (25)</span></a></li>
<li class="toclevel-2"><a href="#System_level_effects_.2826.29"><span class="tocnumber">3.3</span> <span class="toctext">System level effects (26)</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Nicotine_addiction"><span class="tocnumber">4</span> <span class="toctext">Nicotine addiction</span></a>
<ul>
<li class="toclevel-2"><a href="#Components_of_Addiction._Animal_Models._.2827.29"><span class="tocnumber">4.1</span> <span class="toctext">Components of Addiction.   Animal Models. (27)</span></a></li>
<li class="toclevel-2"><a href="#Nicotine_Addiction_at_the_circuit_and_cellular_level."><span class="tocnumber">4.2</span> <span class="toctext">Nicotine Addiction at the circuit and cellular level.</span></a>
<ul>
<li class="toclevel-3"><a href="#.E2.80.9COutside-In.E2.80.9D_Mechanisms_.2828.29"><span class="tocnumber">4.2.1</span> <span class="toctext">“Outside-In” Mechanisms (28)</span></a></li>
<li class="toclevel-3"><a href="#Upregulation_via_.E2.80.9CInside-Out.E2.80.9D_Mechanisms_.2829.29"><span class="tocnumber">4.2.2</span> <span class="toctext">Upregulation via “Inside-Out” Mechanisms (29)</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Recent_Genetic_Data_.2830.29"><span class="tocnumber">4.3</span> <span class="toctext">Recent Genetic Data (30)</span></a></li>
<li class="toclevel-2"><a href="#Drugs_for_smoking_cessation.3B_Harm_Reduction_.2831.29"><span class="tocnumber">4.4</span> <span class="toctext">Drugs for smoking cessation; Harm Reduction (31)</span></a></li>
</ul>
</li>
</ul>
</td></tr></table>
<h1> <span class="mw-headline" id="Drugs_Bind_to_Neurotransmitter_Transporters_.2822.29">Drugs Bind to Neurotransmitter Transporters (22)</span></h1>
<p><strong>3 classes of proteins transport ions across membranes</strong>
<ul><li> Figure 11.4 Passive and Active Transport Compared is from a section of Chapter 11 of Alberts et. al. Molecular Biology of the Cell<br />
</li></ul>
<a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/?term=11.4%20%20passive%20and%20active%20transport%20compared%20AND%20mboc4%5Bbook%5D">Active Transport Is Mediated by Carrier Proteins Coupled to an Energy Source.</a>
<ul><li> Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition.
</li></ul>
New York: Garland Science; 2002.</p>
<p><strong>Dopamine transporter (DAT) knockout mice experiment</strong></p>
<p>*<a rel="nofollow" class="external text" href="http://www.jneurosci.org/content/18/6/1979.full.pdf">Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter</a> article is open-access<br />
Jones SR, Gainetdinov RR, Wightman RM, Caron MG. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci. 1998 Mar 15;18(6):1979-86.
<ul><li> The article is publicly available from the Journal of Neuroscience
</li><li> from <a rel="nofollow" class="external text" href="http://www.wakehealth.edu/PhysPharm/Faculty/Sara-R-Jones-PhD.htm">Dr Sara R. Jones lab</a>, which conducts research measuring neurotransmitters in animal models of drug and alcohol abuse at Wake Forest University.</p>
</li></ul>

<hr />
<h1> <span class="mw-headline" id="Neurotransmitter_Transporters_as_Molecules_.2823.29">Neurotransmitter Transporters as Molecules (23)</span></h1>
<p><strong>“Alternating Access” Model for ion-coupled transporters</strong>
<ul><li> Figure 11.9 Three Types of Carrier-Mediated Transport is from a section of Chapter 11 of Alberts et. al. Molecular Biology of the Cell<br />
</li></ul>
<a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/?term=Three%20Types%20of%20Carrier-Mediated%20Transport%20AND%20mboc4%5Bbook%5D">Active Transport Can Be Driven by Ion Gradients.</a>
<ul><li> Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition.
</li></ul>
New York: Garland Science; 2002.</p>
<p><strong>SSRIs bind tightly to, and stabilize, intermediate state(s) of the serotonin transporter. A Dynamic, Low-Resolution Model</strong>
<a rel="nofollow" class="external text" href="http://www.jneurosci.org/content/17/7/2257.full.pdf">Cao et al., J Neurosci 1997</a>article is open-access <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/9065487">PubMed Abstract</a>
<ul><li> Cao Y, Mager S, Lester HA. H+ permeation and pH regulation at a mammalian serotonin transporter. J Neurosci. 1997 Apr 1;17(7):2257-66. PubMed PMID: 9065487.
</li><li> <a rel="nofollow" class="external text" href="http://www.its.caltech.edu/~halweb/">from Professor Lester's Lab</a></p>
</li></ul>

<p><strong>Brain of GABA Transporter-GFP ‘Knock-in” Mouse</strong>
<ul><li><a rel="nofollow" class="external text" href="http://www.jneurosci.org/content/22/23/10251.full.pdf">Chiu et al. GABA Transporter–GFP Counted in Knock-In Mice</a> article is open-access <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/12451126">PubMed Abstract</a>
</li><li> from Professor Lester's Lab
</li><li>Chiu CS, Jensen K, Sokolova I, Wang D, Li M, Deshpande P, Davidson N, Mody I, Quick MW, Quake SR, Lester HA. Number, density, and surface/cytoplasmic distribution of GABA transporters at presynaptic structures of knock-in mice carrying GABA transporter subtype 1-green fluorescent protein fusions. J Neurosci. 2002 Dec 1;22(23):10251-66. PubMed PMID: 12451126.
</li><li> <a rel="nofollow" class="external text" href="http://www.its.caltech.edu/~halweb/">from Professor Lester's Lab</a></p>
</li></ul>

<hr />
<h1> <span class="mw-headline" id="Recreational_Drugs:">Recreational  Drugs:</span></h1>
<h2> <span class="mw-headline" id="Overview_.2824.29">Overview (24)</span></h2>
<hr />
<h2> <span class="mw-headline" id="Targets_.2825.29">Targets (25)</span></h2>
<hr />
<h2> <span class="mw-headline" id="System_level_effects_.2826.29">System level effects (26)</span></h2>
<p><strong>fMRI measurements on a hallucinogenic 5-HT2A agonist in human brain</strong>
<ul><li> <a rel="nofollow" class="external text" href="http://www.pnas.org/content/109/6/2138.full.pdf+html">Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin</a> article is open-access
</li><li> Robin L. Carhart-Harris, David Erritzoe, Tim Williams, James M. Stone, Laurence J. Reed, Alessandro Colasanti, Robin J. Tyacke, Robert Leech, Andrea L. Malizia, Kevin Murphy, Peter Hobden, John Evans, Amanda Feilding, Richard G. Wise, and David J. Nutt From the Cover: Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin PNAS 2012 109 (6) 2138-2143; published ahead of print January 23, 2012, doi:10.1073/pnas.1119598109</p>
</li></ul>

<h1> <span class="mw-headline" id="Nicotine_addiction">Nicotine addiction</span></h1>
<h2> <span class="mw-headline" id="Components_of_Addiction._Animal_Models._.2827.29">Components of Addiction.   Animal Models. (27)</span></h2>
<p><strong>Chronic nicotine causes tolerance of dopamine release</strong>
<ul><li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/15453263">PubMed Abstract of Rahman, Zhang, Engleman, &amp; Corrigall, 2004</a>
</li><li> No open access - you can follow the paywall link to view the figures and associated captions
</li><li>Rahman S, Zhang J, Engleman EA, Corrigall WA. Neuroadaptive changes in the
</li></ul>
mesoaccumbens dopamine system after chronic nicotine self-administration: a
microdialysis study. Neuroscience. 2004;129(2):415-24. PubMed PMID: 15501598.</p>
<h2> <span class="mw-headline" id="Nicotine_Addiction_at_the_circuit_and_cellular_level.">Nicotine Addiction at the circuit and cellular level.</span></h2>
<h3> <span class="mw-headline" id=".E2.80.9COutside-In.E2.80.9D_Mechanisms_.2828.29">“Outside-In” Mechanisms (28)</span></h3>
<ul>
<li><p>Sulzer D. <a rel="nofollow" class="external text" href="http://www.cell.com/neuron/retrieve/pii/S0896627311001073">How addictive drugs disrupt presynaptic dopamine neurotransmission</a>. 
Neuron. 2011 Feb 24;69(4):628-49. doi: 10.1016/j.neuron.2011.02.010. 
The article is open-access, click on the full text and it will work (without being a subscriber.)</p></li>
<li><p>You can find it the above paper and several great other review papers <a rel="nofollow" class="external text" href="http://blogs.plos.org/neuroanthropology/2011/03/08/neuron-open-access-reviews-on-addiction/">Neuron – Open-Access Reviews on Addiction</a><br />
Follow the links and you will find pdf versions.</p></li>
</ul>
<hr />
<h3> <span class="mw-headline" id="Upregulation_via_.E2.80.9CInside-Out.E2.80.9D_Mechanisms_.2829.29">Upregulation via “Inside-Out” Mechanisms (29)</span></h3>
<p><strong>Cellular and subcellular specificity of Selective α4* nAChR Upregulation</strong>
<ul><li> <a rel="nofollow" class="external text" href="http://www.jneurosci.org/content/27/31/8202.full.pdf">Nashmi et al J Neurosci 2007</a> article is open-access <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/17670967">PubMed Abstract</a>
</li><li>  Nashmi R, Xiao C, Deshpande P, McKinney S, Grady SR, Whiteaker P, Huang Q, McClure-Begley T, Lindstrom JM, Labarca C, Collins AC, Marks MJ, Lester HA. Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 2007 Aug 1;27(31):8202-18. PubMed PMID: 17670967.
</li><li> <a rel="nofollow" class="external text" href="http://www.its.caltech.edu/~halweb/">from Professor Lester's Lab</a></p>
</li></ul>

<ul>
<li><a rel="nofollow" class="external text" href="http://www.jneurosci.org/content/29/40/12428.full.pdf">Xiao et al, J Neurosci 2009</a> article is open-access <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/19812319">PubMed Abstract</a></li>
<li>Xiao C, Nashmi R, McKinney S, Cai H, McIntosh JM, Lester HA. Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J Neurosci. 2009 Oct 7;29(40):12428-39. doi:10.1523/JNEUROSCI.2939-09.2009. PubMed PMID: 19812319; PubMed Central PMCID:PMC2787412.</li>
<li><a rel="nofollow" class="external text" href="http://www.its.caltech.edu/~halweb/">from Professor Lester's Lab</a></li>
</ul>
<p><strong>Either activation and/or desensitization can be amplified by upregulation</strong>
<ul><li><a rel="nofollow" class="external text" href="http://orphanin.caltech.edu/~lester/world/Reprints%20from%20our%20lab/2011/Miwa-neuron-2011.pdf">Miwa et al, Neuron 2011</a> reprint at Lester Lab <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/21482353">PubMed Abstract</a>
</li><li> Miwa JM, Freedman R, Lester HA. Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron. 2011 Apr 14;70(1):20-33. doi: 10.1016/j.neuron.2011.03.014. Review. PubMed PMID: 21482353.
</li><li> <a rel="nofollow" class="external text" href="http://www.its.caltech.edu/~halweb/">from Professor Lester's Lab</a></p>
</li></ul>

<p><strong>“Inside-out” action leads nicotine to upregulate α4β2 nicotinic receptors</strong>
<ul><li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/15944128">PubMed Abstract of Sallette et al, Neuron 2005</a> Open access - follow link and then go to full text
</li><li> Sallette J, Pons S, Devillers-Thiery A, Soudant M, Prado de Carvalho L, Changeux JP, Corringer PJ. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron. 2005 May 19;46(4):595-607. PubMed PMID: 15944128.</p>
</li></ul>

<ul>
<li><a rel="nofollow" class="external text" href="http://molpharm.aspetjournals.org/content/68/6/1839.long">Kuryatov et al., Mol. Pharm. 2005</a> Open access <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/16183856">PubMed Abstract</a></li>
<li>Kuryatov A, Luo J, Cooper J, Lindstrom J. Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Mol Pharmacol. 2005 Dec;68(6):1839-51. Epub 2005 Sep 23. PubMed PMID: 16183856.</li>
</ul>
<p><strong>Two possible results of nicotine-nAChR binding in the endoplasmic reticulum</strong>  </p>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268041/">RIC-3: a nicotinic acetylcholine receptor chaperone</a></li>
<li>An article I found about nicotinic acetylcholine receptor (nAChR ) chaperones while searching for other references. I found it amazing that a type of nAChR  is similar in the nematode <i>C. elegans</i> as well as insects and mammals.</li>
<li>Millar, N. S. (2008), RIC-3: a nicotinic acetylcholine receptor chaperone. British Journal of Pharmacology, 153: S177–S183. doi: 10.1038/sj.bjp.0707661  </li>
</ul>
<hr />
<h2> <span class="mw-headline" id="Recent_Genetic_Data_.2830.29">Recent Genetic Data (30)</span></h2>
<ul>
<li>The Saccone et al. study was a two-stage effort, the first stage did the genotyping of the single nucleotide polymorphisms (SNPs), while the second stage SNPs for individual genotyping were selected.</li>
</ul>
<p><strong>Genome-Wide Association Scans (GWAS) identify single-nucleotide polymorphisms (SNPs) affecting nicotine addiction</strong> 
<ul><li> <a rel="nofollow" class="external text" href="http://hmg.oxfordjournals.org/content/16/1/24.full.pdf">Stage 1 Saccone et al, Hum. Mol. Gen., 2007</a>Open access <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/17158188">PubMed Abstract</a>
</li><li> Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF, Swan GE, Rutter J, Bertelsen S, Fox L, Fugman D, Goate AM, Hinrichs AL, Konvicka K, Martin NG, Montgomery GW, Saccone NL, Saccone SF, Wang JC, Chase GA, Rice JP, Ballinger DG. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet. 2007 Jan 1;16(1):24-35. Epub 2006 Dec 7. PubMed PMID: 17158188; PubMed Central PMCID: PMC2278047.</p>
</li></ul>

<p><strong>Candidate gene approach identifies a nicotine addiction-related SNP in the coding region of the nicotinic receptor α5 subunit</strong></p>
<ul>
<li><a rel="nofollow" class="external text" href="http://hmg.oxfordjournals.org/content/16/1/36.full.pdf">Stage 2 Saccone et al, Hum. Mol. Gen., 2007</a>Open access <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/17135278">PubMed Abstract</a></li>
<li>Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau O, Swan GE, Goate AM, Rutter J, Bertelsen S, Fox L, Fugman D, Martin NG, Montgomery GW, Wang JC, Ballinger DG, Rice JP, Bierut LJ. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet. 2007 Jan 1;16(1):36-49. Epub 2006 Nov 29. PubMed PMID: 17135278; PubMed Central PMCID: PMC2270437.</li>
</ul>
<hr />
<h2> <span class="mw-headline" id="Drugs_for_smoking_cessation.3B_Harm_Reduction_.2831.29">Drugs for smoking cessation; Harm Reduction (31)</span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.pnas.org/content/109/23/9173.full.pdf">Ulens et al . PNAS 2012</a>Open access <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/22619328">PubMed Abstract</a></li>
<li>Billen B, Spurny R, Brams M, van Elk R, Valera-Kummer S, Yakel JL, Voets T, Bertrand D, Smit AB, Ulens C. Molecular actions of smoking cessation drugs at α4β2 nicotinic receptors defined in crystal structures of a homologous binding protein. Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9173-8. doi:10.1073/pnas.1116397109. Epub 2012 May 22. PubMed PMID: 22619328; PubMed Central PMCID: PMC3384148.</li>
</ul>

<!-- 
NewPP limit report
Preprocessor node count: 14/1000000
Post-expand include size: 0/2097152 bytes
Template argument size: 0/2097152 bytes
Expensive parser function count: 0/100
-->


</div><div class="printfooter">
Retrieved from "<a href="https://share.coursera.org/wiki/index.php?title=Drugsandbrain:References_3&amp;oldid=6012">https://share.coursera.org/wiki/index.php?title=Drugsandbrain:References_3&amp;oldid=6012</a>"</div>
					<div id='catlinks' class='catlinks catlinks-allhidden'></div>					<!-- end content -->
									</div>
			</div>